List of nationally authorised medicinal products

Size: px
Start display at page:

Download "List of nationally authorised medicinal products"

Transcription

1 21 February 2018 EMA/208334/2018 Human Medicines Evaluation Division Active substance: ibuprofen / pseudoephedrine Procedure no.: PSUSA/ / Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0) Facsimile +44 (0) Send a question via our website An agency of the European Union European Medicines Agency, Reproduction is authorised provided the source is acknowledged.

2 BoxaGrippal 200 mg/30 mg - Dolorflu akut 200 mg/30 mg - Ibuduo, 200 mg/30 mg film-coated tablets WICK DayMed Duo 200mg/30mg HCl Pfizer 200 mg/30 mg comprimés enrobés HCl Pfizer 200 mg/30 mg omhulde tabletten HCl Pfizer 200mg/30 mg überzogene Tabletten hydrochloride Boehringer Ingelheim 200 mg/30 mg hydrochloride Boehringer Ingelheim 200 mg/30 mg filmomhulde tabletten IBUPFEN/PSEUDOEPHED RINE HYDCHLORI SANOFI 200 mg/30 mg Ibuprofen/pseudoephedrine hydrochloride Sanofi 200 mg/30 mg filmomhulde tabletten /H/4352/ SANOFI-AVENTIS AT OSTERREICH /H/4184/ SANDOZ AT AT/H/0614/ ORIFARM GENERICS A/S AT IT/H/0331/ RATIOPHARM ARZNEIMITTEL VERTRBS- AT /H/0420/001 BE PFIZER B.V. BE /H/0420/001 BE PFIZER B.V. BE /H/0420/001 BE PFIZER B.V. BE /H/4352/001 BE BOEHRINGER INGELHEIM INTERNATIONAL /H/4352/001 BE BOEHRINGER INGELHEIM INTERNATIONAL /H/4352/001 BE SANOFI BELGIUM BE /H/4352/001 BE SANOFI BELGIUM BE BE BE EMA/208334/2018 Page 2/18

3 Ibuprofen/pseudoephedrine hydrochloride Sanofi 200 mg/30 mg filmomhulde tabletten filmomhulde tabletten filmomhulde tabletten filmomhulde tabletten ЕКСТРАЛГИН КОЛД 200 mg/30 mg филмирани таблетки ЕКСТРАЛГИН КОЛД 200 mg/30 mg филмирани таблетки ЕКСТРАЛГИН КОЛД 200 mg/30 mg филмирани таблетки /H/4352/001 BE SANOFI BELGIUM BE not available ZENTIVA, K.S. BG not available ZENTIVA, K.S. BG not available ZENTIVA, K.S. BG EMA/208334/2018 Page 3/18

4 ЕКСТРАЛГИН КОЛД 200 mg/30 mg филмирани таблетки Ибупром Синус 200 mg/30 mg обвити таблетки Мукогрип 200 mg/30 mg филмирани таблетки Нурофен Стопколд 200 mg/30 mg филмирани таблетки Олитабс 200 mg/30 mg филмирани таблетки Олитабс 200 mg/30 mg филмирани таблетки Олитабс 200 mg/30 mg филмирани таблетки Олитабс 200 mg/30 mg филмирани таблетки Hexatab Headcold Relief 200 mg/30 mg, Hexatab Headcold Relief 200 mg/30 mg, Hexatab Headcold Relief 200 mg/30 mg, Hexatab Headcold Relief 200 mg/30 mg, not available ZENTIVA, K.S. BG not available US PHARMACIA SP. Z O.O. BG /H/4352/ BOEHRINGER INGELHEIM INTERNATIONAL not available RECKITT BENCKISER INTERNATIONAL /H/4183/001/DC MCNEIL PDUCTS /H/4183/001/DC MCNEIL PDUCTS /H/4183/001/DC MCNEIL PDUCTS /H/4183/001/DC MCNEIL PDUCTS /H/4183/ JOHNSON & JOHNSON HELLAS CONSUMER AE /H/4183/ JOHNSON & JOHNSON HELLAS CONSUMER AE /H/4183/ JOHNSON & JOHNSON HELLAS CONSUMER AE /H/4183/ JOHNSON & JOHNSON HELLAS CONSUMER AE BG BG BG BG BG BG CY CY CY CY EMA/208334/2018 Page 4/18

5 Mucocold 200mg/30mg /H/4352/ BOEHRINGER INGELHEIM INTERNATIONAL NUFEN Cold & Flu not available RECKITT BENCKISER CY HELLAS CHEMICALS ABEE Grippecton 200 mg/30 mg /H/4188/001 07/155/16-C KREWEL MEUSELBACH CZ potahované tablety Modafen potahované not available 07/136/98-C ZENTIVA, K.S. CZ tablety Modafen potahované not available 07/136/98-C ZENTIVA, K.S. CZ tablety Modafen potahované not available 07/136/98-C ZENTIVA, K.S. CZ tablety Modafen potahované not available 07/136/98-C ZENTIVA, K.S. CZ tablety Nurofen StopGrip potahované tablety not available 07/612/96-C RECKITT BENCKISER INTERNATIONAL CZ Robicold 200 mg/30 mg obalené tablety BoxaGrippal Erkältungssaft 200 mg/10 ml + 30 mg/10 ml Suspension zum Einnehmen BoxaGrippal Erkältungstabletten 200 mg / 30 mg Dolormin Grippal 200 mg/30 mg Dolormin Grippal 200 mg/30 mg Dolormin Grippal 200 mg/30 mg GRIPOMED 200 mg/30 mg /H/0420/001 07/040/15-C PFIZER CORPORATION /H/5545/ SANOFI-AVENTIS UTSCHLAND /H/4352/ SANOFI-AVENTIS UTSCHLAND /H/4182/001/DC JOHNSON & JOHNSON /H/4182/001/DC JOHNSON & JOHNSON /H/4182/001/DC JOHNSON & JOHNSON /H/4185/ PHARMASWISS ČESKÁ REPUBLIKA S.R.O. CY CZ EMA/208334/2018 Page 5/18

6 IbuHEXAL Grippal 200 mg/30 mg Ibuprofen/Pseudoephedrinh ydrochlorid Angelini 200 mg/30 mg Ibuprofen/Pseudoephedrinh ydrochlorid Krewel 200 mg/30 mg IbuSinex 200 mg/30 mg ratiogrippal 200 mg/30 mg Spalt Effekt 30mg/200 mg überzogene Tabletten SpaltGrippal 200 mg/30 mg Weichkapseln WICK DuoGrippal 200 mg/30 mg Febrilek 200 mg / 30 mg õhukese polümeerikattega tabletid Bisolfren 200 mg/30 mg comprimidos recubiertos con película /H/4184/ HEXAL AG /H/4186/ AZN CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.P.A. /H/4188/ KREWEL MEUSELBACH /H/4187/ DIAPHARM & CO. KG /H/4183/001/DC JOHNSON & JOHNSON /H/4183/001/DC JOHNSON & JOHNSON /H/4183/001/DC JOHNSON & JOHNSON /H/4183/001/DC JOHNSON & JOHNSON not available RATIOPHARM FR/H/0238/ PFIZER CONSUMER /H/5671/ PFIZER CONSUMER IT/H/0331/ WICK PHARMA ZWEIGNRLASSUNG R PCTER & GAMBLE /H/4185/ PHARMASWISS ČESKÁ REPUBLIKA S.R.O. /H/4352/ BOEHRINGER INGELHEIM INTERNATIONAL EE ES EMA/208334/2018 Page 6/18

7 Gripaduo 200 mg/30 mg comprimidos recubiertos con película NUFEN RHUME, comprimé pelliculé RHINADVIL RHUME IBUPFENE/PSEUDOEPHE DRINE, comprimé enrobé RHINUREFLEX, comprimé pelliculé Gripomed 200 mg/30 mg Hexatab Headcold Relief 200 mg/30 mg, Hexatab Headcold Relief 200 mg/30 mg, Hexatab Headcold Relief 200 mg/30 mg, Hexatab Headcold Relief 200 mg/30 mg, Mucocold 200mg/30mg IT/H/0331/ LABORATORIOS VICKS, S.L. not available RECKITT BENCKISER FRANCE FR/H/0238/ PFIZER SANTE FAMILIALE SAS not available RECKITT BENCKISER FRANCE /H/4185/ /14/ PHARMASWISS ČESKÁ REPUBLIKA S.R.O. /H/4183/001/DC 70000/ JOHNSON & JOHNSON HELLAS CONSUMER AE /H/4183/001/DC 70000/ JOHNSON & JOHNSON HELLAS CONSUMER AE /H/4183/001/DC 70000/ JOHNSON & JOHNSON HELLAS CONSUMER AE /H/4183/001/DC 70000/ JOHNSON & JOHNSON HELLAS CONSUMER AE /H/4352/ BOEHRINGER INGELHEIM INTERNATIONAL NUFEN Cold & Flu not available 44616/10 RECKITT BENCKISER GR HELLAS CHEMICALS ABEE Fidiprofen flu 200 mg+ 30 mg tablete not available UP/I /11-01/363 FIDIFARM D.O.O. HR ES FR FR FR GR GR GR GR GR GR EMA/208334/2018 Page 7/18

8 Ibutren Flu 200 mg/30 mg filmom obložene tablete Nurofen Cold and Flu 200 mg + 30 mg filmom obložene tablete filmom obložene tablete filmom obložene tablete filmom obložene tablete filmom obložene tablete RHINORELF 200 mg + 30 mg tablete Advil Cold 200 mg/30 mg bevont tabletta Advil Cold 200 mg/30 mg bevont tabletta Advil Cold Rapid 200 mg/30 mg lágy kapszula Advil Cold Rapid 200 mg/30 mg lágy kapszula Advil Cold Rapid 200 mg/30 mg lágy kapszula Advil Cold Rapid 200 mg/30 mg lágy kapszula ALGOFLEX COLD 200 mg/30 mg filmtabletta /H/4184/001 HR-H SANDOZ D.O.O. HR not available UP/I /11-02/20 RECKITT BENCKISER (CATIA) D.O.O. /H/4183/001/DC HR-H JOHNSON & JOHNSON S.E.D.O.O. HR /H/4183/001/DC HR-H JOHNSON & JOHNSON HR S.E.D.O.O. /H/4183/001/DC HR-H JOHNSON & JOHNSON HR S.E.D.O.O. /H/4183/001/DC HR-H JOHNSON & JOHNSON HR S.E.D.O.O. not available UP/I /11-01/379 JADRAN-GALENSKI HR LABORATORIJ D.D. /H/0420/001 OGYI-T-22705/02 PFIZER CORPORATION HU /H/0420/001 OGYI-T-22705/01 PFIZER CORPORATION HU /H/5670/001 OGYI-T-22705/05 PFIZER CORPORATION HU /H/5670/001 OGYI-T-22705/03 PFIZER CORPORATION HU /H/5670/001 OGYI-T-22705/06 PFIZER CORPORATION HU /H/5670/001 OGYI-T-22705/04 PFIZER CORPORATION HU not available OGYI-T-22831/01 SANOFI-AVENTIS ZRT HU HR EMA/208334/2018 Page 8/18

9 ALGOFLEX COLD 200 mg/30 mg filmtabletta ALGOFLEX COLD 200 mg/30 mg filmtabletta Ibuprofen/Pszeudoefedrin Wick 200 mg/30 mg filmtabletta Ibuprofen/Pszeudoefedrin Wick 200 mg/30 mg filmtabletta Ibuprofen/Pszeudoefedrin Wick 200 mg/30 mg filmtabletta Nurofen Cold and Flu 200 mg/30 mg filmtabletta Nurofen Cold and Flu 200 mg/30 mg filmtabletta Advil Cold & Flu Coated Tablets Ibuprofen 200 mg Pseudoephedrine Hydrochloride 30 mg Advil Sinus Relief Soft Capsules Ibuprofen 200 mg Pseudoephedrine hydrochloride 30 mg Hydrochloride 200mg/30mg film coated tablets Hydrochloride 200mg/30mg film coated tablets not available OGYI-T-22831/03 SANOFI-AVENTIS ZRT HU not available OGYI-T-22831/02 SANOFI-AVENTIS ZRT HU IT/H0331/001 OGYI-T-22836/01 WICK PHARMA ZWEIGNRLASSUNG R PCTER & GAMBLE IT/H/0331/001 OGYI-T-22836/02 WICK PHARMA ZWEIGNRLASSUNG R PCTER & GAMBLE IT/H/0331/001 OGYI-T-22836/03 WICK PHARMA ZWEIGNRLASSUNG R PCTER & GAMBLE not available OGYI-T-6797/02 RECKITT BENCKISER INTERNATIONAL not available OGYI-T-6797/01 RECKITT BENCKISER INTERNATIONAL /H/0420/001 PA 0822/164/001 PFIZER IRELAND /H/5670/001 PA 822/164/002 PFIZER IRELAND /H/4182/001/DC PA823/067/001 MCNEIL (IRELAND) /H/4182/001/DC PA823/067/001 MCNEIL (IRELAND) HU HU HU HU HU EMA/208334/2018 Page 9/18

10 Hydrochloride 200mg/30mg film coated tablets Hydrochloride 200mg/30mg film coated tablets Non-Drowsy Sudapro Head Cold 200mg / 30mg Filmcoated Tablets Non-Drowsy Sudapro Head Cold 200mg / 30mg Filmcoated Tablets Non-Drowsy Sudapro Head Cold 200mg / 30mg Filmcoated Tablets Non-Drowsy Sudapro Head Cold 200mg / 30mg Filmcoated Tablets Nurofen Cold & Flu Filmcoated Tablets, Ibuprofen 200mg, Pseduoephedrine Hydrochloride 30mg Nurofen Sinus and Pain Film-Coated Tablets Ibuprofen 200mg Pseudoephedrine Hydrochloride 30mg Nurofen Sinus and Pain Film-Coated Tablets Ibuprofen 200mg Pseudoephedrine Hydrochloride 30mg ACTISINU 200 mg/30 mg, ACTISINU 200 mg/30 mg, /H/4182/001/DC PA823/067/001 MCNEIL (IRELAND) /H/4182/001/DC PA823/067/001 MCNEIL (IRELAND) /H/4183/001/DC PA 823/68/1 MCNEIL (IRELAND) /H/4183/001/DC PA 823/68/1 MCNEIL (IRELAND) /H/4183/001/DC PA 823/68/1 MCNEIL (IRELAND) /H/4183/001/DC PA 823/68/1 MCNEIL (IRELAND) not available PA 979/33/1 RECKITT BENCKISER IRELAND LTD. not available PA 979/65/1 RECKITT BENCKISER IRELAND LTD. not available PA 979/65/1 RECKITT BENCKISER IRELAND LTD. /H/4183/001/DC JOHNSON & JOHNSON S.P.A. /H/4183/001/DC JOHNSON & JOHNSON S.P.A. IT IT EMA/208334/2018 Page 10/18

11 ACTISINU 200 mg/30 mg, ACTISINU 200 mg/30 mg, Momenxsin 200 mg/30 mg Momenxsin 200 mg/30 mg Momenxsin 200 mg/30 mg Momenxsin 200 mg/30 mg NUFEN INFLUENZA E RAFFREDDORE 200 mg + 30 mg Compresse Rivestite NUFEN INFLUENZA E RAFFREDDORE 200 mg + 30 mg Compresse Rivestite Vicks Flu Action 200 mg/30 mg compresse rivestite con film Vicks Flu Action 200 mg/30 mg compresse rivestite con film Vicks Flu Action 200 mg/30 mg compresse rivestite con film /H/4183/001/DC JOHNSON & JOHNSON S.P.A. IT /H/4183/001/DC JOHNSON & JOHNSON IT S.P.A. /H/4186/ AZN CHIMICHE IT RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.P.A. /H/4186/ AZN CHIMICHE IT RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.P.A. /H/4186/ AZN CHIMICHE IT RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.P.A. /H/4186/ AZN CHIMICHE IT RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.P.A. not available RECKITT BENCKISER IT INTERNATIONAL not available RECKITT BENCKISER IT INTERNATIONAL IT/H/0331/ PCTER & GAMBLE S.R.L IT IT/H/0331/ PCTER & GAMBLE S.R.L IT IT/H/0331/ PCTER & GAMBLE S.R.L IT EMA/208334/2018 Page 11/18

12 ZerinoDek 200 mg/30 mg ZerinoDek 200 mg/30 mg Daikol 200 mg/30 mg plėvele dengtos tabletės ILOXEN 200 mg/30 mg plėvele dengtos tabletės ILOXEN 200 mg/30 mg plėvele dengtos tabletės ILOXEN 200 mg/30 mg plėvele dengtos tabletės ILOXEN 200 mg/30 mg plėvele dengtos tabletės HCl Pfizer 200 mg / 30 mg Comprimés enrobé IBUPFEN/PSEUDOEPHED RINE HYDCHLORI SANOFI 200 mg/30 mg hydrochloride Sanofi 200 mg/30 mg IbuSinex 200 mg/30 mg comprimé pelliculé ILOXEN 200 mg/30 mg apvalkotās tabletes /H/4352/ SANOFI SPA IT /H/4352/ SANOFI SPA IT not available LT/1/16/3982/001 SIA INGEN PHARMA LT /H/4185/001 LT/1/16/3881/001 PHARMASWISS ČESKÁ REPUBLIKA S.R.O. LT /H/4185/001 LT/1/16/3881/002 PHARMASWISS ČESKÁ LT REPUBLIKA S.R.O. /H/4185/001 LT/1/16/3881/003 PHARMASWISS ČESKÁ LT REPUBLIKA S.R.O. /H/4185/001 LT/1/16/3881/004 PHARMASWISS ČESKÁ LT REPUBLIKA S.R.O. /H/0420/ PFIZER B.V. LU /H/4352/ SANOFI BELGIUM LU /H/4352/ SANOFI BELGIUM LU /H/4187/ DIAPHARM & CO. KG LU /H/4183/001/DC JOHNSON & JOHNSON /H/4183/001/DC JOHNSON & JOHNSON /H/4183/001/DC JOHNSON & JOHNSON /H/4183/001/DC JOHNSON & JOHNSON /H/4185/ PHARMASWISS ČESKÁ REPUBLIKA S.R.O. LU LU LU LU LV EMA/208334/2018 Page 12/18

13 Nurofen Antigrip 200 mg/30 not available RECKITT BENCKISER LV mg apvalkotās tabletes (POLAND) S.A. Advil Cold & Flu Coated not available MA 969/00201 PFIZER CONSUMER MT Tablets LTD. Advil Cold & Flu Coated not available MA 969/00201 PFIZER CONSUMER MT Tablets LTD. Advil Sinus Relief Soft /H/5670/001 MA969/00202 PFIZER CORPORATION MT Capsules Ibuprofen 200 mg Pseudoephedrine hydrochloride 30 mg Nurofen Cold & Flu not available MA 190/00404 RECKITT BENCKISER MT INTERNATIONAL Acatar Zatoki, 200 mg + 30 mg, tabletki powlekane not available US PHARMACIA SP. Z O.O. PL Advil Zatoki, 200 mg + 30 mg, tabletki powlekane /H/0420/ PFIZER CORPORATION PL /H/4185/ PHARMASWISS ČESKÁ PL REPUBLIKA S.R.O. not available HASCO-LEK PL Efedoxin, 200 mg + 30 mg, tabletki powlekane IBUM GRIP, 200 mg + 30 mg, tabletki powlekane Ibum Zatoki Max, 400 mg + not available HASCO-LEK PL 60 mg, tabletki powlekane Ibum Zatoki, 200 mg + 30 not available HASCO-LEK PL mg, tabletki powlekane /H/4188/ KREWEL MEUSELBACH PL hydrochloride Krewel, 200 mg + 30 mg, tabletki powlekane IBUPM ZATOKI, 200 mg not available 9650 US PHARMACIA SP. Z O.O. PL + 30 mg, tabletki powlekane Infex Zatoki IT-H DC TEVA PHARMACEUTICALS PL POLSKA SP. Z O.O. EMA/208334/2018 Page 13/18

14 Laboratoria PolfaŁódź ZATOKI, 200 mg + 30 mg, tabletki Metafen ZATOKI, 200 mg + 30 mg, tabletki Metafen ZATOKI, 200 mg + 30 mg, tabletki MODAFEN EXTRA GRIP, 200 mg + 30 mg, tabletki powlekane MODAFEN EXTRA GRIP, 200 mg + 30 mg, tabletki powlekane MODAFEN EXTRA GRIP, 200 mg + 30 mg, tabletki powlekane Nurofen Zatoki, 200 mg + 30 mg, tabletki powlekane Sudafed Extra, 200 mg + 30 mg, tabletki powlekane Sudafed Extra, 200 mg + 30 mg, tabletki powlekane Sudafed Extra, 200 mg + 30 mg, tabletki powlekane Sudafed Extra, 200 mg + 30 mg, tabletki powlekane Bisolpront 200 mg + 30 mg comprimidos revestidos por película Bisolpront 200 mg + 30 mg comprimidos revestidos por película not available BIO PFIL POLSKA SP Z OO not available ZAKLADY FARMACEUTYCZNE "POLPHARMA" SPOLKA AKCYJNA PL not available ZAKLADY PL FARMACEUTYCZNE "POLPHARMA" SPOLKA AKCYJNA not available 9603 ZENTIVA, K.S. PL not available 9603 ZENTIVA, K.S. PL not available 9603 ZENTIVA, K.S. PL not available 7787 RECKITT BENCKISER (POLAND) S.A. /H/4183/001/DC MCNEIL PDUCTS /H/4183/001/DC MCNEIL PDUCTS /H/4183/001/DC MCNEIL PDUCTS /H/4183/001/DC MCNEIL PDUCTS /H/4352/ SANOFI - PDUTOS FARMACEUTICOS LDA /H/4352/ SANOFI - PDUTOS FARMACEUTICOS LDA PL PL PL PL PL PL PT PT EMA/208334/2018 Page 14/18

15 Larofen Plus 200mg/30mg Modafen 200 mg/30 mg Modafen 200 mg/30 mg Modafen 200 mg/30 mg Modafen 200 mg/30 mg Nurofen Răceală şi Gripă 200 mg/30 mg comprimate filmate Nurofen Răceală şi Gripă 200 mg/30 mg comprimate filmate not available 9424/2016/01 LAPHARM SRL not available 480/2007/02 ZENTIVA, K.S. not available 480/2007/03 ZENTIVA, K.S. not available 480/2007/04 ZENTIVA, K.S. not available 480/2007/01 ZENTIVA, K.S. not available 4144/2011/02 RECKITT BENCKISER INTERNATIONAL not available 4144/2011/01 RECKITT BENCKISER INTERNATIONAL /H/4183/001/DC 8529/2016/03 MCNEIL PDUCTS /H/4183/001/DC 8529/2016/01 MCNEIL PDUCTS /H/4183/001/DC 8529/2016/04 MCNEIL PDUCTS /H/4183/001/DC 8529/2016/02 MCNEIL PDUCTS /H/5670/ /2016/01 PFIZER CORPORATION /H/5670/ /2016/02 PFIZER CORPORATION /H/5670/ /2016/08 PFIZER CORPORATION /H/5670/ /2016/14 PFIZER CORPORATION EMA/208334/2018 Page 15/18

16 /H/5670/ /2016/12 PFIZER CORPORATION /H/5670/ /2016/03 PFIZER CORPORATION /H/5670/ /2016/10 PFIZER CORPORATION /H/5670/ /2016/06 PFIZER CORPORATION /H/5670/ /2016/04 PFIZER CORPORATION /H/5670/ /2016/16 PFIZER CORPORATION /H/5670/ /2016/05 PFIZER CORPORATION /H/5670/ /2016/13 PFIZER CORPORATION /H/5670/ /2016/07 PFIZER CORPORATION /H/5670/ /2016/11 PFIZER CORPORATION /H/5670/ /2016/09 PFIZER CORPORATION /H/5670/ /2016/15 PFIZER CORPORATION EMA/208334/2018 Page 16/18

17 TEDOLFEN 200mg/30mg IT/H/0331/ /2014/01-04 TEVA PHARMACEUTICALS S.R.L Ibuseu, 200 mg/30 mg AT/H/0614/ ORIFARM GENERICS A/S SE filmdragerade tabletter /H/4183/001/DC H/16/02163/004 MCNEIL PDUCTS SI filmsko obložene tablete /H/4183/001/DC H/16/02163/002 MCNEIL PDUCTS SI filmsko obložene tablete /H/4183/001/DC H/16/02163/001 MCNEIL PDUCTS SI filmsko obložene tablete /H/4183/001/DC H/16/02163/003 MCNEIL PDUCTS SI filmsko obložene tablete Grippecton 200 mg/30 mg /H/4188/001 07/0143/16-S KREWEL MEUSELBACH SK filmom obalené tablety MODAFEN 200 mg/30 mg not available 07/0263/01-S ZENTIVA, K.S. SK filmom obalené tablety MODAFEN 200 mg/30 mg not available 07/0263/01-S ZENTIVA, K.S. SK filmom obalené tablety MODAFEN 200 mg/30 mg not available 07/0263/01-S ZENTIVA, K.S. SK filmom obalené tablety NUFEN STOPGRIP not available 07/0662/96-S RECKITT BENCKISER SK INTERNATIONAL Robicold 200 mg/30 mg obalené tablety /H/0420/001 07/0264/14-S PFIZER CORPORATION SK Robicold Rapid 200 mg/30 mg mäkké kapsuly Boots Cold & Flu Relief with Ibuprofen Ibuprofen/ Pseudoephedrine hydrochloride Pfizer 200mg/30mg Capsules /H/5670/001 07/0235/16-S PFIZER CORPORATION SK not available 00014/0600 THE BOOTS COMPANY PLC /H/5671/001 PL 00165/0389 PFIZER CONSUMER LTD. EMA/208334/2018 Page 17/18

18 Nurofen Sinus Pressure & Headache Relief 200mg/30mg Tablets not available PL 00063/0718 RECKITT BENCKISER () Nurofen Cold & Flu not available PL 00063/0375 RECKITT BENCKISER () Nurofen Sinus Relief not available PL 00063/0375 RECKITT BENCKISER () RobiCold Cold & Flu Relief /H/5670/001 PL 00165/0388 PFIZER CONSUMER 200 mg / 30 mg Soft LTD. Capsules RobiCold Sinus Relief 200 /H/0420/001 PL 00165/0391 PFIZER CONSUMER mg, 30 mg Tablets LTD. Sudafed Sinus Pressure & Pain 200mg/30mg filmcoated tablets Sudafed Sinus Pressure & Pain 200mg/30mg filmcoated tablets Sudafed Sinus Pressure & Pain 200mg/30mg filmcoated tablets Sudafed Sinus Pressure & Pain 200mg/30mg filmcoated tablets Sudafed Sinus Pressure & Pain Tablets Sudafed Sinus Pressure & Pain Tablets Sudafed Sinus Pressure & Pain Tablets Sudafed Sinus Pressure & Pain Tablets /H/4183/001 PL 15513/0396 MCNEIL PDUCTS /H/4183/001 PL 15513/0396 MCNEIL PDUCTS /H/4183/001 PL 15513/0396 MCNEIL PDUCTS /H/4183/001 PL 15513/0396 MCNEIL PDUCTS not available PL 15513/0126 MCNEIL PDUCTS not available PL 15513/0126 MCNEIL PDUCTS not available PL 15513/0126 MCNEIL PDUCTS not available PL 15513/0126 MCNEIL PDUCTS EMA/208334/2018 Page 18/18

List of nationally authorised medicinal products

List of nationally authorised medicinal products 06 July 2017 EMA/436040/2017 Human Medicines Evaluation Division Active substance: Procedure no.: PSUSA/00001815/201610 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/231137/2018 Human Medicines Evaluation Division Active substance: fluvoxamine Procedure no.: PSUSA/00001458/201707 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 27 October 2016 EMA/719205/2016 Human Medicines Evaluation Division Active substance: ethinylestradiol / gestodene (except for transdermal application) Procedure no.: PSUSA/00001308/201603 30 Churchill

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 01 December 2016 Human Medicines Evaluation Division Active substance: Procedure no.: PSUSA/00002591/201604 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 1 December 2016 EMA/750653/2016 Human Medicines Evaluation Division Active substance: valganciclovir Procedure no.: PSUSA/00003089/201603 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 January 2017 EMA/36356/2017 Human Medicines Evaluation Division Active substance: hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine Procedure no.: PSUSA/00001696/201605

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/243033/2018 Human Medicines Evaluation Division Active substance: fenofibrate Procedure no.: PSUSA/00001362/201707 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/382206/2018 Human Medicines Evaluation Division Active substance(s): naproxen Procedure No.: PSUSA/00002125/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 17 May 2018 EMA/303456/2018 Human Medicines Evaluation Division Active substance: bromazepam Procedure no.: PSUSA/00000435/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 10 September 2015 EMA/677092/2015 Procedure Management and Committees Support Active substance: glatiramer Procedure no.: PSUSA/00001529/201411 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 29 September 2017 EMA/658556/2017 Procedure Management and Committees Support Active substance: loratadine Procedure no.: PSU/00001907/201702 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 EMA/608492/2018 Human Medicines Evaluation Division Active substance: betahistine Procedure no.: PSUSA/00000389/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 29 November 2018 EMA/880324/2018 Human Medicines Evaluation Division Active substance: enalapril Procedure no.: PSUSA/00001211/201803 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 10 September 2015 EMA/622830/2015 Procedure Management and Committees Support Active substance: azelastine Procedure no.: PSUSA/00000277/201412 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 10 September 2015 EMA/612853/2015 Procedure Management and Committees Support Active substance: tobramycin (nebuliser solution) Procedure no.: PSUSA/00009316/201412 30 Churchill Place Canary Wharf London

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 21 June 2017 EMA/610895/2017 Human Medicines Evaluation Division Active substance: felbamate Procedure no.: PSUSA/00010155/201609 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 08 March 2018 EMA/170163/2018 Human Medicines Evaluation Division Active substance: enalapril / hydrochlorothiazide Procedure no.: PSUSA/00001212/201707 30 Churchill Place Canary Wharf London E14 5EU United

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 January 2018 EMA/24585/2018 Human Medicines Evaluation Division Active substance: esomeprazole / naproxen Procedure no.: PSUSA/00001270/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 8 March 2018 EMA/182668/2018 Human Medicines Evaluation Division Active substance(s): triamcinolone (topical and nasal formulations) Procedure No.: PSUSA/00003017/201707 30 Churchill Place Canary Wharf

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 3 December 2015 EMA/98477/2016 Procedure Management and Committees Support Active substance: acarbose Procedure no.: PSUSA/00000017/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 8 November 2017 EMA/845743/2017 Human Medicines Evaluation Division Active substance: ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus) Procedure no.: PSUSA/00010345/201702 30 Churchill

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 5 November 2015 EMA/230130/2016 Procedure Management and Committees Support Active substance: cabergoline Procedure no.: PSUSA/00000477/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 09 June 2017 EMA/36849/2017 Human Medicines Evaluation Division Active substance(s): brimonidine / timolol Procedure No.: PSUSA/00000431/201609 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/223740/2018 Human Medicines Evaluation Division Active substance: fludarabine Procedure no.: PSUSA/00001406/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/812360/2017 Human Medicines Evaluation Division Active substance(s): mupirocin Procedure No.: PSUSA/00002096/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

BIJSLUITER: INFORMATIE VOOR DE PATIËNT

BIJSLUITER: INFORMATIE VOOR DE PATIËNT BIJSLUITER: INFORMATIE VOOR DE PATIËNT Sitagliptine Teva 25 mg, filmomhulde tabletten Sitagliptine Teva 50 mg, filmomhulde tabletten Sitagliptine Teva 100 mg, filmomhulde tabletten Sitagliptin Read all

More information

Annex I. List of nationally authorised medicinal products and marketing authorisation applications

Annex I. List of nationally authorised medicinal products and marketing authorisation applications Annex I List of nationally authorised medicinal products and marketing authorisation applications 1 Annex IA: Medicinal products recommended for maintenance and marketing authorisation applications for

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 26 October 2017 EMA/690754/2017 Human Medicines Evaluation Division Active substance: fish oil / olive oil / soybean oil / triglycerides mediumchain Procedure no.: PSUSA/00010223/201702 30 Churchill Place

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 14 April 2016 EMA/284169/2016 Procedure Management and Committees Support Active substance: influenza vaccine (split virion, inactivated) (non centrally products) Procedure no.: PSUSA/00010298/201508 30

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/817351/2017 Human Medicines Evaluation Division Active substance: Lidocaine / prilocaine (not centrally authorised product) Procedure no.: PSUSA/00001867/201703 30 Churchill Place

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 24 January 2018 EMA/270645/2015 Human Medicines Evaluation Division Active substance: azithromycin (systemic use formulations) Procedure no.: PSUSA/00010491/201704 30 Churchill Place Canary Wharf London

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 7 July 2016 EMA/437334/2016 Procedure Management and Committees Support Division Active substance: Terazosin Procedure no.: PSUSA/00002895/201511 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 February 2016 EMA/255959/2016 Procedure Management and Committees Support Active substance: calcitonin salmon, synthetic analogue of eel calcitonin Procedure No.: PSUSA/00000494/201506 30 Churchill

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/817337/2017 Human Medicines Evaluation Division Active substance: Itraconazole Procedure no.: PSUSA/00001798/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 28 September 2017 EMA/639167/2017 Human Medicines Evaluation Division Active substance: zanamivir Procedure no.: PSUSA/00003141/201701 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 EMA/619619/2018 Human Medicines Evaluation Division Active substance: haemophilus influenzae / klebsiella ozaenae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Aurobindo 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Aurobindo 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Metfmin HCl Aurobindo 500 mg/ 850 mg/ 1000 mg, film-coated tablets metfmin hydrochlide Read all of this leaflet carefully befe you start taking this medicine.

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 October 2017 EMA/784453/2017 Human Medicines Evaluation Division List of nationally authorised medicinal products Active substance(s): ipratropium / salbutamol Procedure No.: PSUSA/00001781/201701 30

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 EMA/615391/2018 Human Medicines Evaluation Division Active substance: tobramycin (nebuliser solution) (apart from centrally authorised product) Procedure no.: PSUSA/00009316/201712 30

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Mylan 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Mylan 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Metformin HCl Mylan 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine.

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 28 September 2017 EMA/658449/2017 Human Medicines Evaluation Division Active substance: olodaterol Procedure no.: PSUSA/00010245/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

Package leaflet: Information for the patient. Levocetirizine Krka 5 mg film-coated tablets Levocetirizine dihydrochloride

Package leaflet: Information for the patient. Levocetirizine Krka 5 mg film-coated tablets Levocetirizine dihydrochloride Package leaflet: Information for the patient Levocetirizine Krka 5 mg film-coated tablets Levocetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/795271/2017 Human Medicines Evaluation Division Active substance: vinorelbine Procedure no.: PSUSA/00003124/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 13 September 2017 EMA/706786/2017 Human Medicines Evaluation Division Active substance: Octenidine dihydrochloride / phenoxyethanol Procedure no.: PSUSA/00002199/201701 30 Churchill Place Canary Wharf

More information

(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use

(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Austria Austria Bulgaria Bulgaria

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/806830/2017 Human Medicines Evaluation Division Active substance: piroxicam Procedure no.: PSUSA/00002438/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

Annex I. Article 107i of Directive 2001/83/EC. Procedure number: EMEA/H/A-107i/ March 2013 EMA/147828/2013 Patient Health Protection

Annex I. Article 107i of Directive 2001/83/EC. Procedure number: EMEA/H/A-107i/ March 2013 EMA/147828/2013 Patient Health Protection 07 March 2013 EMA/147828/2013 Patient Health Protection Annex I List of the names, pharmaceutical s, strengths of the medicinal products, routes of, marketing authorisation holders in the member states

More information

Annex I. List of nationally authorised medicinal products and marketing authorisation applications

Annex I. List of nationally authorised medicinal products and marketing authorisation applications Annex I List of nationally authorised medicinal products and marketing authorisation applications 1 Annex IA: Medicinal products recommended for maintenance and marketing authorisation applications for

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Etoricoxib

PACKAGE LEAFLET: INFORMATION FOR THE USER. Etoricoxib PACKAGE LEAFLET: INFORMATION FOR THE USER ARCOXIA 30 mg film-coated tablets ARCOXIA 60 mg film-coated tablets ARCOXIA 90 mg film-coated tablets ARCOXIA 120 mg film-coated tablets Etoricoxib Read all of

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 July 2018 EMA/462856/2018 Human Medicines Evaluation Division Active substance: econazole, econazole nitrate / triamcinolone acetonide, econazole nitrate / zinc oxide Procedure no.: PSUSA/00001195/201711

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 1 September 2017 EMA/580096/2017 Human Medicines Evaluation Division Active substance: terbutaline Procedure no.: PSUSA/00002897/201612 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

(Invented) Name. Crestor 5 mg Filmtabletten. Filmtabletten. Filmtabletten. Filmtabletten. Crestor 5 mg Film coated tablets Oral use

(Invented) Name. Crestor 5 mg Filmtabletten. Filmtabletten. Filmtabletten. Filmtabletten. Crestor 5 mg Film coated tablets Oral use Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, route of and marketing authorisation holders in the Member s 1 Austria Austria Austria Austria Belgium Belgium Belgium

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Simvastatin Aurobindo 5 mg film-coated tablets Simvastatin Aurobindo 10 mg film-coated tablets Simvastatin Aurobindo 20 mg film-coated tablets Simvastatin Aurobindo

More information

Referral under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data

Referral under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data 31 May 2018 EMA/372722/2018 Human Medicines Evaluation Division List of the names, pharmaceutical forms, strengths of the medicinal products, routes of, marketing authorisation holders in the member states

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 5 May 2017 EMA/288255/2017 Human Medicines Evaluation Division Active substance: pilocarpine (ophthalmic formulation) Procedure no.: PSUSA/00002410/201608 30 Churchill Place Canary Wharf London E14 5EU

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Arcoxia 60 mg Film coated Tablets Arcoxia 90 mg Film coated Tablets etoricoxib

PACKAGE LEAFLET: INFORMATION FOR THE USER Arcoxia 60 mg Film coated Tablets Arcoxia 90 mg Film coated Tablets etoricoxib PACKAGE LEAFLET: INFORMATION FOR THE USER Arcoxia 60 mg Film coated Tablets Arcoxia 90 mg Film coated Tablets etoricoxib Read all of this leaflet carefully before you start taking this medicine. Keep this

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Sevelamer Carbonate Rowex 800mg Film-coated tablets sevelamer carbonate Read all of this leaflet carefully before you start taking this medicine because it contains

More information

BIJSLUITER: INFORMATIE VOOR DE PATIËNT

BIJSLUITER: INFORMATIE VOOR DE PATIËNT PACKAGE LEAFLET 1 BIJSLUITER: INFORMATIE VOOR DE PATIËNT Cinacalcet 30 mg Teva, filmomhulde tabletten Cinacalcet 60 mg Teva, filmomhulde tabletten Cinacalcet 90 mg Teva, filmomhulde tabletten Cinacalcet

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Tevaquel 25 mg Film-coated Tablets Tevaquel 100 mg Film-coated Tablets Tevaquel 150 mg Film-coated Tablets Tevaquel 200 mg Film-coated Tablets Tevaquel 300

More information

MONTELAIR 10 mg film-coated tablets

MONTELAIR 10 mg film-coated tablets Package leaflet: Information for the user MONTELAIR 10 mg film-coated tablets For adolescents and adults from 15 years Montelukast Read all of this leaflet carefully before you start taking this medicine

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride) PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride) Read all of this leaflet carefully before you start taking this medicine. - Keep

More information

Package leaflet: Information for the user. Tadalafil teva 10 mg film-coated tablet Tadalafil teva 20 mg film-coated tablet tadalafil

Package leaflet: Information for the user. Tadalafil teva 10 mg film-coated tablet Tadalafil teva 20 mg film-coated tablet tadalafil Package leaflet: Information for the user Tadalafil teva 10 mg film-coated tablet Tadalafil teva 20 mg film-coated tablet tadalafil Read all of this leaflet carefully before you start taking this medicine

More information

EUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008

EUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008 European Medicines Agency Doc. Ref. EMEA/357907/2008 P/53/2008 EUROPEAN MEDICINES AGENCY DECISION of 20 July 2008 on the application for agreement of a Paediatric Investigation Plan for Atorvastatin calcium

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 20 July 2016 EMA/270645/2015 Procedure Management and Committees Support Active substance: apomorphine Procedure no.: PSUSA/00000227/201511 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

Product name Strength Pharmaceutical form. Flupirtinmaleat AbZ 100 mg Kapseln. Flupirtinmaleat AL 100 mg Hartkapseln. Awegal inject 164,5 mg / 3 ml

Product name Strength Pharmaceutical form. Flupirtinmaleat AbZ 100 mg Kapseln. Flupirtinmaleat AL 100 mg Hartkapseln. Awegal inject 164,5 mg / 3 ml Annex I List of the names, pharmaceutical s, strengths of the medicinal products, route of, marketing authorisation s in the Member States 1 Bulgaria Estonia Zentiva k.s. 130 U kabelovn Prague 10237 Czech

More information

PACKAGE LEAFLET. Package leaflet: Information for the patient

PACKAGE LEAFLET. Package leaflet: Information for the patient PACKAGE LEAFLET Package leaflet: Information for the patient Etoricoxib 30 mg Film-coated tablets Etoricoxib 60 mg Film-coated tablets Etoricoxib 90 mg Film-coated tablets Etoricoxib120 mg Film-coated

More information

Package leaflet: Information for the user. Clopidogrel 75 mg film-coated tablets. Clopidogrel

Package leaflet: Information for the user. Clopidogrel 75 mg film-coated tablets. Clopidogrel Package leaflet: Information for the user Clopidogrel 75 mg film-coated tablets Clopidogrel Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Please note that this draft Annex I will be updated to amend information on concerned products/mahs

Please note that this draft Annex I will be updated to amend information on concerned products/mahs 22 March 2018 EMA/197481/2018 Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of, applicants, marketing authorisation holders in the member states for for omega-3

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 July 2018 EMA/497430/2018 Human Medicines Evaluation Division Active substance: tafluprost / timolol Procedure no.: PSUSA/00010324/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

Package leaflet: Information for the user. Capecitabine Sandoz 150 mg Film-coated tablets Capecitabine Sandoz 500 mg Film-coated tablets.

Package leaflet: Information for the user. Capecitabine Sandoz 150 mg Film-coated tablets Capecitabine Sandoz 500 mg Film-coated tablets. Package leaflet: Information for the user 150 mg Film-coated tablets 500 mg Film-coated tablets capecitabine Read all of this leaflet carefully before you start taking this medicine because it contains

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Simvastatin Bluefish 10 mg film-coated tablets Simvastatin Bluefish 20 mg film-coated tablets Simvastatin Bluefish 40 mg film-coated tablets Simvastatin Bluefish

More information

Decentralised Procedure. Public Assessment Report

Decentralised Procedure. Public Assessment Report Bundesinstitut für Arzneimittel und Medizinprodukte Decentralised Procedure Public Assessment Report IBU-Lysin-ratiopharm 342 mg Filmtabletten IBU-Lysin-ratiopharm 684 mg Filmtabletten Ibu-Lysin AbZ Migräne

More information

Interested parties (organisations or individuals) that commented on the draft document as released for consultation.

Interested parties (organisations or individuals) that commented on the draft document as released for consultation. 25 January 2018 EMA/CHMP/729976/2017 Committee for Medicinal Products for Human Use (CHMP) Overview of comments received on 'Paracetamol oral use, immediate release formulations product-specific bioequivalence

More information

Simvastatin Teva 10 mg Film-coated Tablets Simvastatin Teva 20 mg Film-coated Tablets Simvastatin Teva 40 mg Film-coated Tablets Simvastatin

Simvastatin Teva 10 mg Film-coated Tablets Simvastatin Teva 20 mg Film-coated Tablets Simvastatin Teva 40 mg Film-coated Tablets Simvastatin PACKAGE LEAFLET: INFORMATION FOR THE USER Simvastatin Teva 10 mg Film-coated Tablets Simvastatin Teva 20 mg Film-coated Tablets Simvastatin Teva 40 mg Film-coated Tablets Simvastatin Read all of this leaflet

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Etoricoxib Teva 30 mg Film-coated Tablets Etoricoxib Teva 60 mg Film-coated Tablets Etoricoxib Teva 90 mg Film-coated Tablets Etoricoxib Teva 120 mg Film-coated

More information

European Medicines Agency decision

European Medicines Agency decision EMA/398442/2016 European Medicines Agency decision P/0191/2016 of 15 July 2016 on the acceptance of a modification of an agreed paediatric investigation plan for agomelatine (Valdoxan, Thymanax), (EMEA-001181-PIP01-11-M03)

More information

Prasugrel hydrochloride film-coated tablets 5 mg and 10 mg product-specific bioequivalence guidance

Prasugrel hydrochloride film-coated tablets 5 mg and 10 mg product-specific bioequivalence guidance 31 May 2018 EMA/CHMP/158772/2016/Rev.1 Committee for Medicinal Products for Human Use (CHMP) Prasugrel hydrochloride film-coated tablets 5 mg and 10 mg Draft Agreed by Pharmacokinetics Working Party April

More information

European Medicines Agency decision

European Medicines Agency decision EMA/741983/2016 European Medicines Agency decision P/0324/2016 of 2 December 2016 on the acceptance of a modification of an agreed paediatric investigation plan for linagliptin (Trajenta), (EMEA-000498-PIP01-08-M06)

More information

European Medicines Agency decision

European Medicines Agency decision EMA/776083/2014 European Medicines Agency decision P/0001/2015 of 7 January 2015 on the acceptance of a modification of an agreed paediatric investigation plan for linagliptin (Trajenta) (EMEA-000498-PIP01-08-M04)

More information

Package leaflet: Information for the user. Kalcipos-D forte 500 mg/800 IU film-coated tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the user. Kalcipos-D forte 500 mg/800 IU film-coated tablets. Calcium/cholecalciferol (Vitamin D3) Package leaflet: Information for the user Kalcipos-D forte 500 mg/800 IU film-coated tablets Calcium/cholecalciferol (Vitamin D3) Read all of this leaflet carefully before you start using this medicine

More information

European Medicines Agency decision

European Medicines Agency decision EMA/497687/2017 European Medicines Agency decision P/0245/2017 of 4 September 2017 on the refusal of a paediatric investigation plan and on the refusal of a deferral and on the granting of a waiver for

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Atorvastatin 10 mg Film-coated Tablets Atorvastatin 20 mg Film-coated Tablets Atorvastatin 40 mg Film-coated Tablets Atorvastatin 80 mg Film-coated Tablets

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER 60 mg Film coated Tablets 90 mg Film coated Tablets 120 mg Film coated Tablets (etoricoxib) (etoricoxib) (etoricoxib) Read all of the leaflet carefully before

More information

(Invented) Name Strength Pharmaceutical form. Effortil comp. - Tropfen 2 mg/ml, 10 mg/ml. 2.5 mg prolonged-release capsule, hard

(Invented) Name Strength Pharmaceutical form. Effortil comp. - Tropfen 2 mg/ml, 10 mg/ml. 2.5 mg prolonged-release capsule, hard Annex I List of the names, pharmaceutical (s), strength(s) of the medicinal product(s), route(s) of, marketing authorisation holder(s) in the member states 1 Boehringer Ingelheim RCV GmbH & Co KG, Dr.

More information

European Medicines Agency decision

European Medicines Agency decision EMA/75416/2018 European Medicines Agency decision P/0042/2018 of 16 February 2018 on the acceptance of a modification of an agreed paediatric investigation plan for dasatinib (Sprycel), (EMEA-000567-PIP01-09-M05)

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 September 2017 EMA/604559/2017 Human Medicines Evaluation Division Active substance: iron / parenteral preparations Procedure no.: PSUSA/00010236/201701 30 Churchill Place Canary Wharf London E14 5EU

More information

Package Leaflet: Information for the user. Tadalafil 10 mg film-coated tablets Tadalafil

Package Leaflet: Information for the user. Tadalafil 10 mg film-coated tablets Tadalafil Package Leaflet: Information for the user Tadalafil 10 mg film-coated tablets Tadalafil Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Marketing Authorisation Holder Invented name Strength Pharmaceutical Form. Postinor 1500 Mikrogramm-Tablette

Marketing Authorisation Holder Invented name Strength Pharmaceutical Form. Postinor 1500 Mikrogramm-Tablette Annex I List of the names, pharmaceutical form, strengths of the medicinal products, route of, marketing authorisation holders in the Member States 1 Levonorgestrel-containing emergency contraceptive medicinal

More information

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Prof. Ing. Juraj Nemec, CSc. Masaryk University, Czech Republic, Size of government

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 EMA/612350/2018 Human Medicines Evaluation Division Active substance: azelastine Procedure no.: PSUSA/00000277/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

Package leaflet: Information for the patient. Non-Drowsy Sudapro Head Cold 200 mg/30 mg Film-Coated tablets Ibuprofen/Pseudoephedrine hydrochloride

Package leaflet: Information for the patient. Non-Drowsy Sudapro Head Cold 200 mg/30 mg Film-Coated tablets Ibuprofen/Pseudoephedrine hydrochloride Package leaflet: Information for the patient Non-Drowsy Sudapro Head Cold 200 mg/30 mg Film-Coated tablets Ibuprofen/Pseudoephedrine hydrochloride For adults and adolescents from 15 years and older Read

More information

European Medicines Agency decision

European Medicines Agency decision EMA/434825/2017 European Medicines Agency decision P/0235/2017 of 9 August 2017 on the agreement of a paediatric investigation plan and on the granting of a deferral for venetoclax (Venclyxto), (EMEA-002018-PIP02-16)

More information

Interested parties (organisations or individuals) that commented on the draft document as released for consultation.

Interested parties (organisations or individuals) that commented on the draft document as released for consultation. 31 May 2018 EMA/CHMP/258276/2017 Committee for Medicinal Products for Human Use (CHMP) Overview of comments received on 'Dabigatran etexilate, hard capsules, 75 mg, 110 mg and 150 mg productspecific bioequivalence

More information

European Medicines Agency decision

European Medicines Agency decision EMA/38339/2017 European Medicines Agency decision P/0021/2017 of 3 February 2017 on the acceptance of a modification of an agreed paediatric investigation plan for dupilumab (EMEA- 001501-PIP02-13-M02)

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 Human Medicines Evaluation Division Active substance(s): hypericum perforatum L., herba Procedure No.: PSUSA/00001701/201801 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

Package leaflet: Information for the patient. Cosimprel 10 mg/5 mg, film-coated tablets. bisoprolol fumarate/perindopril arginine

Package leaflet: Information for the patient. Cosimprel 10 mg/5 mg, film-coated tablets. bisoprolol fumarate/perindopril arginine Package leaflet: Information for the patient Cosimprel 10 mg/5 mg, film-coated tablets bisoprolol fumarate/perindopril arginine Read all of this leaflet carefully before you start taking this medicine

More information

TEPZZ A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 9/20 (2006.

TEPZZ A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 9/20 (2006. (19) TEPZZ 96746A_T (11) EP 2 96 746 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 13.01.16 Bulletin 16/02 (1) Int Cl.: A61K 9/00 (06.01) A61K 9/ (06.01) (21) Application number: 102377.1

More information

Implementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO

Implementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO Implementation Report on the patient safety Recommendation 2009/C 151/01 Healthcare Systems Unit DG SANCO Published 15 November 2012 REPORT FROM THE COMMISSION TO THE COUNCIL on the basis of Member States'

More information